Balyasny Asset Management’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Balyasny Asset Management’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,000	Closed	-$1.98M	–	3481
2022 Q3	$1.98M	Hold	200,000	–	–	0.01%	1504
2022 Q2	$1.96M	Hold	200,000	–	–	0.01%	1422
2022 Q1	$1.96M	Hold	200,000	–	–	0.01%	1369
2021 Q4	$1.95M	Hold	200,000	–	–	0.01%	1246
2021 Q3	$1.94M	Hold	200,000	–	–	0.01%	1151
2021 Q2	$1.94M	Hold	200,000	–	–	0.01%	1033
2021 Q1	$1.92M	Buy	+200,000	New	+$1.95M	0.01%	1051

Balyasny Asset Management's SSAA Position: Q4 2022 in Review

Balyasny Asset Management sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 200,000 shares — an estimated $1.98M sold.

Balyasny Asset Management first reported a position in SSAA in Q1 2021 and held it in 7 quarters. The position peaked at $1.98M in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Balyasny Asset Management reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Balyasny Asset Management sold 200,000 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $1.98M.
Balyasny Asset Management first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2021 and held it in 7 quarters.
Balyasny Asset Management's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $1.98M in Q3 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.